CLAIRE ALLEN: Open Payments
NPI 1609546845 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 10 payments from 8 companies in 2025. Trend: 2023 $149 · 2024 $752 · 2025 $726
Food & beverage: $627Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $208 |
| GENZYME CORPORATION | 1 | $130 |
| AstraZeneca Pharmaceuticals LP | 2 | $130 |
| INTUITIVE SURGICAL, INC. | 1 | $110 |
| SEAGEN INC. | 1 | $99 |
| Janssen Biotech, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: SARCLISA, KYPROLIS, Da Vinci Surgical System, IMDELLTRA (AMG757), DARZALEX, KEYTRUDA.
Industry payments across IN — which companies pay providers there.
